Jonathan S. Wolin
First SEC filing: Sept. 13, 2019 · Latest: Sept. 13, 2019
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | JAGX | A | 11,740 | · | · | 11,740 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 11, 2025 | JAGX | A | 11,740 | · | · | 11,938 Direct | +5929.29% | Acquired | (price as of 2026-10-02) |
| June 24, 2025 | JAGX | A | 18,262 | · | · | 9,000 Direct | · | Acquired | (price as of 2026-10-02) |
| June 24, 2025 | JAGX | A | 9,462 | $50000.00 | $473,100,000 | 9,462 Direct | · | Acquired | -100.0% (price as of 2026-10-02) |
| June 24, 2025 | JAGX | D | 9,000 | $50000.00 | $450,000,000 | 0 Direct | -100.00% | Disposed | -100.0% (price as of 2026-10-02) |
| March 31, 2025 | JAGX | P | 9,000 | · | · | 9,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 31, 2025 | JAGX | P | 9,000 | $50000.00 | $450,000,000 | 9,000 Direct | · | Acquired | -100.0% (price as of 2026-10-02) |
| Oct. 8, 2024 | JAGX | A | 39,376 | · | · | 39,376 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 8, 2024 | JAGX | A | 4,922 | · | · | 4,955 Direct | +14915.15% | Acquired | (price as of 2026-10-02) |
| May 17, 2024 | JAGX | M | 871 | · | · | 871 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| May 17, 2024 | JAGX | M | 871 | · | · | 2,012 Direct | +76.34% | Acquired | (price as of 2026-10-02) |
| April 5, 2024 | JAGX | A | 89 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 5, 2024 | JAGX | M | 89 | · | · | 1,141 Direct | +8.46% | Acquired | (price as of 2026-10-02) |
| Aug. 14, 2023 | JAGX | A | 196,628 | · | · | 197,680 Direct | +18690.87% | Acquired | (price as of 2026-10-02) |
| May 17, 2023 | JAGX | M | 871 | · | · | 1,742 Direct | -33.33% | Disposed | (price as of 2026-10-02) |
| May 17, 2023 | JAGX | M | 871 | · | · | 1,052 Direct | +481.22% | Acquired | (price as of 2026-10-02) |
| April 5, 2023 | JAGX | A | 88 | · | · | 88 Direct | · | Acquired | (price as of 2026-10-02) |
| April 5, 2023 | JAGX | M | 88 | · | · | 181 Direct | +94.62% | Acquired | (price as of 2026-10-02) |
| Dec. 31, 2022 | JAGX | P | 317 | $0.03 | $10 | 6,983 Direct | +4.76% | Acquired | -100.0% (price as of 2026-10-02) |
| Dec. 27, 2022 | JAGX | D | 21,112 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| April 5, 2022 | JAGX | A | 6,666 | · | · | 13,333 Direct | +99.99% | Acquired | (price as of 2026-10-02) |
| April 5, 2022 | JAGX | M | 6,666 | · | · | 6,666 Direct | · | Acquired | (price as of 2026-10-02) |
| March 28, 2022 | JAGX | A | 196,018 | · | · | 196,018 Direct | · | Acquired | (price as of 2026-10-02) |
| April 5, 2021 | JAGX | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| April 5, 2021 | JAGX | A | 120,000 | · | · | 120,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 20, 2020 | JAGX | A | 59,753 | · | · | 59,753 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | JAGX | Stock Option (right to buy) [F1] | Common Stock | $1.44 | Dec. 11, 2035 | 11,740 | Acquired |
| June 24, 2025 | JAGX | Warrant to Purchase Common Stock | Common Stock | $2.70 | Dec. 24, 2026 | 18,262 | Acquired |
| June 24, 2025 | JAGX | Convertible Promissory Note | Common Stock | $5.56 | · | 9,462 | Acquired |
| June 24, 2025 | JAGX | Convertible Promissory Note | Common Stock | $5.56 | · | 9,000 | Disposed |
| March 31, 2025 | JAGX | Warrant to Purchase Common Stock | Common Stock | $5.43 | March 31, 2030 | 9,000 | Acquired |
| March 31, 2025 | JAGX | Convertible Promissory Note | Common Stock | $5.56 | · | 9,000 | Acquired |
| Oct. 8, 2024 | JAGX | Stock option (right to buy) [F1] | Common Stock | $1.29 | Oct. 8, 2034 | 39,376 | Acquired |
| May 17, 2024 | JAGX | Restricted stock units | Common Stock | · | · | 871 | Disposed |
| April 5, 2024 | JAGX | Restricted stock units | Common Stock | · | · | 89 | Disposed |
| May 17, 2023 | JAGX | Restricted stock units | Common Stock | · | · | 871 | Disposed |
| April 5, 2023 | JAGX | Restricted stock units | Common Stock | · | · | 88 | Acquired |
| Dec. 27, 2022 | JAGX | Employee Stock Option (right to buy) | Common Stock | $5.97 | April 5, 2031 | 21,112 | Disposed |
| April 5, 2022 | JAGX | Restricted stock units | Common Stock | · | · | 6,666 | Acquired |
| March 28, 2022 | JAGX | Restricted stock units [F1] | Common Stock | · | · | 196,018 | Acquired |
| April 5, 2021 | JAGX | Restricted stock units [F1] | Common Stock | · | · | 60,000 | Acquired |
| April 5, 2021 | JAGX | Stock option (right to buy) [F1] | Common Stock | $1.99 | April 5, 2031 | 120,000 | Acquired |
| March 20, 2020 | JAGX | Stock Option (right to buy) [F1] | Common Stock | $0.45 | March 20, 2030 | 59,753 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $412,777 | · | · | · | · | · | $60,947 | $506,525 |
| 2024 | $400,584 | $58,935 | · | · | · | · | $60,568 | $574,208 |
| 2023 | $396,520 | · | · | · | · | · | $61,093 | $562,789 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.